Antigen processing and presentation in human muscle: Cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 132-143

  Wiendl, Heinz ^a   Lautwein, Alfred ^a   Mitsdörffer, Meike ^a   Krause, Sabine ^b   Erfurth, Stella ^a   Wienhold, Wolfgang ^a   Morgalla, Matthias ^a   Weber, Ekkehard ^c   Overkleeft, Herman S ^d   Lochmüller, Hanns ^b   Melms, Arthur ^a   Tolosa, Eva ^a   Driessen, Christoph ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Antigen processing; Cathepsin; Immuneproteases; Inflammatory myopathies; Muscle immunobiology

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; ENZYME INHIBITOR; GAMMA INTERFERON; HLA DM ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MUSCLE BIOPSY; MUSCLE CELL; MYOBLAST; MYOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 20244366658     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00093-6     Document Type: Article

References (53)

1. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95:1994;166-172.
2. Behrens L., Kerschensteiner M., Misgeld T., Goebels N., Wekerle H., Hohlfeld R. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J. Immunol. 161:1998;5943-5951.
3. Benaroch P., Yilla M., Raposo G., Ito K., Miwa K., Geuze H.J., Ploegh H.L. How MHC class II molecules reach the endocytic pathway. EMBO J. 14:1995;37-49.
4. Bender A., Ernst N., Iglesias A., Dornmair K., Wekerle H., Hohlfeld R. T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J. Exp. Med. 181:1995;1863-1868.
5. Blau H.M., Springer M.L. Muscle-mediated gene therapy. N. Engl. J. Med. 333:1995;1554-1556.
6. Curnow S.J., Willcox N., Vincent A. Induction of primary immune responses by allogeneic human myoblasts: dissection of the cell types required for proliferation, IFNgamma secretion and cytotoxicity. J. Neuroimmunol. 86:1998;53-62.
7. Curnow J., Corlett L., Willcox N., Vincent A. Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response. J. Neuroimmunol. 115:2001;127-134.
8. Dalakas M.C. Inflammatory myopathies. Recent advances in pathogenesis and therapy. Adv. Neurol. 88:2002;253-271.
9. Davis H.L., Michel M.L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1993;1847-1851.
10. Driessen C., Bryant R.A., Lennon-Dumenil A.M., Villadangos J.A., Bryant P.W., Shi G.P., Chapman H.A., Ploegh H.L. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 147:1999;775-790.
11. Fiebiger E., Meraner P., Weber E., Fang I.F., Stingl G., Ploegh H., Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193:2001;881-892.
12. Gallardo E., de Andres I., Illa I. Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis. J. Neuropathol. Exp. Neurol. 60:2001;847-855.
13. Garlepp M.J., Chen W., Tabarias H., Baines M., Brooks A., McCluskey J. Antigen processing and presentation by a murine myoblast cell line. Clin. Exp. Immunol. 102:1995;614-619.
14. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen-presenting cells. J. Immunol. 149:1992;661-667.
15. Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., Johnson M.A., Wekerle H., Tschopp J., Jenne D., Hohlfeld R. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97:1996;2905-2910.
16. Greenberg S.A., Sanoudou D., Haslett J.N., Kohane I.S., Kunkel L.M., Beggs A.H., Amato A.A. Molecular profiles of inflammatory myopathies. Neurology. 59:2002;1170-1182.
17. Hohlfeld R., Engel A.G. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am. J. Pathol. 136:1990;503-508.
18. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
19. Hohlfeld R., Engel A.G., Goebels N., Behrens L. Cellular immune mechanisms in inflammatory myopathies. Curr. Opin. Rheumatol. 9:1997;520-526.
20. Illa I., Leon-Monzon M., Dalakas M.C. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann. Neurol. 31:1992;46-52.
21. Inukai A., Kuru S., Liang Y., Takano A., Kobayashi Y., Sakai M., Doyu M., Sobue G. Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis. Muscle Nerve. 23:2000;385-392.
22. Kumamoto T., Ueyama H., Sugihara R., Kominami E., Goll D.E., Tsuda T. Calpain and cathepsins in the skeletal muscle of inflammatory myopathies. Eur. Neurol. 37:1997;176-181.
23. Lautwein A., Burster T., Lennon-Dumenil A.M., Overkleeft H.S., Weber E., Kalbacher H., Driessen C. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 32:2002;3348-3357.
24. Lundberg I., Brengman J.M., Engel A.G. Analysis of cytokine expression in muscle in inflammatory myopathies. Duchenne dystrophy, and non-weak controls. J. Neuroimmunol. 63:1995;9-16.
25. Mantegazza R., Hughes S.M., Mitchell D., Travis M., Blau H.M., Steinman L. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma. Neurology. 41:1991;1128-1132.
26. Mantegazza R., Gebbia M., Mora M., Barresi R., Bernasconi P., Baggi F., Cornelio F. Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: implications for the immunopathogenesis of muscle autoimmune diseases. J. Neuroimmunol. 68:1996;53-60.
27. Michaelis D., Goebels N., Hohlfeld R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol. 143:1993;1142-1149.
28. Morgan J.E., Partridge T.A. Cell transplantation and gene therapy in muscular dystrophy. BioEssays. 14:1992;641-645.
29. Murata K., Dalakas M.C. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am. J. Pathol. 155:1999;453-460.
30. Nagaraju K. Immunological capabilities of skeletal muscle cells. Acta Physiol. Scand. 171:2001;215-223.
31. Nagaraju K., Raben N., Merritt G., Loeffler L., Kirk K., Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin. Exp. Immunol. 113:1998;407-414.
32. Nagaraju K., Raben N., Villalba M.L., Danning C., Loeffler L.A., Lee E., Tresser N., Abati A., Fetsch P., Plotz P.H. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells. Clin. Immunol. 92:1999;161-169.
33. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L: critical role in li degradation and CD4 T cell selection in the thymus. Science. 280:1998;450-453.
34. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., Rosloniec E.F., Elliott E.A., Rudensky A.Y. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 10:1999;207-217.
35. Palmer J.T., Rasnick D., Klaus J.L., Bromme D. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38:1995;3193-3196.
36. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 93:1998;1135-1145.
37. Pluger E.B., Boes M., Alfonso C., Schroter C.J., Kalbacher H., Ploegh H.L., Driessen C. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32:2002;467-476.
38. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1994;1275-1287.
39. Riese R.J., Chapman H.A. Cathepsins and compartmentalization in antigen presentation [see comments]. Curr. Opin. Immunol. 12:2000;107-113.
40. Riese R.J., Shi G.P., Villadangos J., Stetson D., Driessen C., Lennon-Dumenil A.M., Chu C.L., Naumov Y., Behar S.M., Ploegh H., Locksley R., Chapman H.A. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity. 15:2001;909-919.
41. Saegusa K., Ishimaru N., Yanagi K., Arakaki R., Ogawa K., Saito I., Katunuma N., Hayashi Y. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110:2002;361-369.
42. Schwarz G., Boehncke W.H., Braun M., Schroter C.J., Burster T., Flad T., Dressel D., Weber E., Schmid H., Kalbacher H. Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma. J. Invest. Dermatol. 119:2002;44-49.
43. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., Chapman H.A. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 10:1999;197-206.
44. Shi G.P., Bryant R.A., Riese R., Verhelst S., Driessen C., Li Z., Bromme D., Ploegh H.L., Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:2000;1177-1186.
45. Storm van's Gravesande K., Layne M.D., Ye Q., Le L., Baron R.M., Perrella M.A., Santambrogio L., Silverman E.S., Riese R.J. IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J. Immunol. 168:2002;4488-4494.
46. Villadangos J.A., Ploegh H.L. Proteolysis in MHC class II antigen presentation: who's in charge? Immunity. 12:2000;233-239.
47. Villadangos J.A., Riese R.J., Peters C., Chapman H.A., Ploegh H.L. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186:1997;549-560.
48. Warrens A.N., Zhang J.Y., Sidhu S., Watt D.J., Lombardi G., Sewry C.A., Lechler R.I. Myoblasts fail to stimulate T cells but induce tolerance. Int. Immunol. 6:1994;847-853.
49. Wiendl H., Behrens L., Maier S., Johnson M.A., Weiss E.H., Hohlfeld R. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann. Neurol. 48:2000;679-684.
50. Wiendl H., Malotka J., Holzwarth B., Weltzien H.U., Wekerle H., Hohlfeld R., Dornmair K. An autoreactive gd T-cell receptor derived from a polymyositis lesion. J. Immunol. 169:2002;515-521.
51. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Weiss E.H., Dichgans J., Lochmuller H., Hohlfeld R., Melms A., Weller M. The nonclassical MHC-molecule HLA-G protects muscle cells from immune mediated lysis: implications for myoblast transplantation and gene therapy. Brain. 126:2003;176-185.
52. Wiendl H., Mitsdoerffer M., Schneider D., Melms A., Lochmuller H., Hohlfeld R., Weller M. Muscle fibers and cultured muscle cells express the B7.1/2 related costimulatory molecule ICOSL: implications for the pathogenesis of inflammatory myopathies. Brain. 165:2003;. (in press).
53. Zuk J.A., Fletcher A. Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate. J. Clin. Pathol. 41:1988;410-414.